BioMarin Pharmaceutical, Inc. (BMRN)
64.08
+0.66
(+1.04%)
USD |
NASDAQ |
Feb 20, 12:02
BioMarin Pharmaceutical Price : 64.08 for Feb. 20, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Amicus Therapeutics, Inc. | 14.34 |
| Gilead Sciences, Inc. | 151.80 |
| Merck & Co., Inc. | 121.43 |
| AbbVie, Inc. | 225.16 |
| Biogen, Inc. | 192.02 |
Price Related Metrics
| PE Ratio | 24.01 |
| PS Ratio | 4.062 |
| PEG Ratio | 0.3955 |
| Price to Book Value | 2.033 |
| Price to Free Cash Flow | 15.17 |
| Earnings Yield | 4.16% |
| Market Cap | 12.31B |
| PEGY Ratio | 0.3955 |
| Operating PE Ratio | 14.65 |
| Normalized PE Ratio | 17.96 |